相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular targeted therapy: A new avenue in glioblastoma treatment
Oula El Atat et al.
ONCOLOGY LETTERS (2023)
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
Harpinder K. Brar et al.
PHARMACEUTICS (2023)
Impact of Regorafenib on Endothelial Transdifferentiation of Glioblastoma Stem-like Cells
Pauline Deshors et al.
CANCERS (2022)
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Manali Tilak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives
Ana Laura V. Alves et al.
STEM CELL RESEARCH & THERAPY (2021)
Evolving role of regorafenib for the treatment of advanced cancers
Axel Grothey et al.
CANCER TREATMENT REVIEWS (2020)
Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients
Armin Sebastian Guntner et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Liling Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
Glioblastoma vs temozolomide: can the red queen race be won?
Anjali Arora et al.
CANCER BIOLOGY & THERAPY (2019)
Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway
Pauline Deshors et al.
CELL DEATH & DISEASE (2019)
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients
Pia S. Zeiner et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
Giuseppe Lombardi et al.
LANCET ONCOLOGY (2019)
Endothelial trans-differentiation in glioblastoma recurring after radiotherapy
Ivana De Pascalis et al.
MODERN PATHOLOGY (2018)
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Martina Da Ros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting aggressive cancer stem cells in glioblastoma
Tracy Seymour et al.
FRONTIERS IN ONCOLOGY (2015)
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models
Estelle Daudigeos-Dubus et al.
PLOS ONE (2015)
Mechanisms of Glioma-Associated Neovascularization
Matthew E. Hardee et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Understanding cancer stem cell heterogeneity and plasticity
Dean G. Tang
CELL RESEARCH (2012)
Transdifferentiation of Glioblastoma Stem-Like Cells into Mural Cells Drives Vasculogenic Mimicry in Glioblastomas
Steve Scully et al.
JOURNAL OF NEUROSCIENCE (2012)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
